Publisher
Games Published by EpiXR Games: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $5.3KRevenue estimates for the 6 Steam games published by EpiXR Games, ranked by estimated net revenue. Available estimated lifetime net (USD): $5.3K.
Catalog Est. Lifetime Net (USD)
$5.3K
Estimates for 2 of 6 tracked games
Tracked games
6
Top Earner
Endless Deaths
$2.9K
Coverage: 6 tracked titles; 2 with net estimates; 4 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Publisher. These are lifetime estimates for games credited to EpiXR Games; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2024-10-31–2025-06-23 (may include announced dates).
Largest title accounts for 53.5% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–6 of the top 6 displayed entries, from 6 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–6 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 | Endless Deaths | $2.9K | 92%Positive (13) | Feb 21, 2025 |
| 2 | The Last Light | $2.5K | 100%Positive (11) | Jan 17, 2025 |
| 3 | House of Horror - 7 Psychos | — | (0) | Oct 31, 2024 |
| 4 | Beyond Memories – Tale of the Lost Souls | — | (0) | Dec 13, 2024 |
| 5 | Beyond Memories – Darkness of the Soul | — | (0) | Jan 10, 2025 |
| 6 | Beyond Memories – Tales of the Heart | — | (0) | Jun 23, 2025 |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.